These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38523233)
1. Immunochemistry-based quantification of tumor-infiltrating lymphocytes and immunoscore as prognostic biomarkers in bladder cancer. Rejeb SB; Elfekih S; Kouki N; Boulma R; Khouni H J Egypt Natl Canc Inst; 2024 Mar; 36(1):9. PubMed ID: 38523233 [TBL] [Abstract][Full Text] [Related]
2. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy. Yu A; Mansure JJ; Solanki S; Siemens DR; Koti M; Dias ABT; Burnier MM; Brimo F; Kassouf W PLoS One; 2018; 13(10):e0205746. PubMed ID: 30308033 [TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor. Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257 [TBL] [Abstract][Full Text] [Related]
4. CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder. Sun ZJ; Zhao JW; Zhao M; Chen Y; Zhang X; Li HC; Wu GQ; Zhang DH Anticancer Drugs; 2023 Aug; 34(7):844-851. PubMed ID: 36563023 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of immunoscore related markers in bladder cancer. Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861 [TBL] [Abstract][Full Text] [Related]
6. The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results. Selvi I; Demirci U; Bozdogan N; Basar H Int Urol Nephrol; 2020 Jan; 52(1):21-34. PubMed ID: 31541404 [TBL] [Abstract][Full Text] [Related]
7. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer. Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889 [TBL] [Abstract][Full Text] [Related]
8. High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer. Hülsen S; Lippolis E; Ferrazzi F; Otto W; Distel L; Fietkau R; Denzinger S; Breyer J; Burger M; Bertz S; Eckstein M; Ebner A; Hartmann A; Geppert CI Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182484 [TBL] [Abstract][Full Text] [Related]
9. The prognostic values of tumor-infiltrating neutrophils, lymphocytes and neutrophil/lymphocyte rates in bladder urothelial cancer. Liu K; Zhao K; Wang L; Sun E Pathol Res Pract; 2018 Aug; 214(8):1074-1080. PubMed ID: 29803657 [TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma. Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy. Li XD; Huang CW; Liu ZF; Jiang LJ; Chen JW; Xie D; Zhou FJ; Lu HM; Liu ZW Ann Surg Oncol; 2019 Nov; 26(12):4148-4156. PubMed ID: 31376036 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma. Yao Q; Bao X; Xue R; Liu H; Liu H; Li J; Dong J; Duan Z; Ren M; Zhao J; Song Q; Yu H; Zhu Y; Lu J; Meng Q Medicine (Baltimore); 2017 Apr; 96(17):e6735. PubMed ID: 28445292 [TBL] [Abstract][Full Text] [Related]
13. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma. Wang T; Zhang D; Tang D; Heng Y; Lu LM; Tao L J Cancer Res Clin Oncol; 2023 Aug; 149(9):5627-5636. PubMed ID: 36520215 [TBL] [Abstract][Full Text] [Related]
14. Density and location of CD3 Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients. Zhang D; Tang D; Heng Y; Zhu XK; Zhou L; Tao L; Lu LM Laryngoscope; 2021 Apr; 131(4):E1249-E1255. PubMed ID: 33107987 [TBL] [Abstract][Full Text] [Related]
16. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors. Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival. Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789 [TBL] [Abstract][Full Text] [Related]
18. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients. Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183 [TBL] [Abstract][Full Text] [Related]
19. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder. Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441 [TBL] [Abstract][Full Text] [Related]
20. Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer. Eriksen AC; Andersen JB; Kristensson M; dePont Christensen R; Hansen TF; Kjær-Frifeldt S; Sørensen FB Diagn Pathol; 2017 Aug; 12(1):65. PubMed ID: 28851404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]